Kanadevia Corp. Logo

Kanadevia Corp. (HIZOF)

OTC

Currency in USD
7.60
0.00 (0.00%)

Closed

Oct 8, 2026

Day's Range

7.60
7.60

52 wk Range

6.56
7.75

Overview - HIZOF - Kanadevia Corp.

Key Statistics

Valuation

Enterprise Value

426.10M

P/E (Trailing)

‪18.09‬

Price / Sales (TTM)

‪0.0019‬

Price / Book

‪1.03‬

EV / EBITDA

‪0.01‬

Profitability

Profit Margin

‪2.24%‬

Operating Margin

‪-1.69%‬

Return on Assets

‪1.39%‬

Return on Equity

‪7.75%‬

Ownership

Shares Outstanding

168.25M

Float

156.06M

Held by Insiders

‪1.77%‬

Held by Institutions

‪58.80%‬

Price stats

Beta

‪0.50‬

50-Day Avg

‪7.69‬

200-Day Avg

‪7.27‬

Dividends

Payout Ratio

‪37.75%‬

Frequency

Annual

Shariah Compliance

Shariah Compliant

Report Date: Feb 20, 2025

Screened by Zoya using the AAOIFI methodology.

News Teaser - HIZOF - Kanadevia Corp.

News & Analysis

View all news

Market Cap - HIZOF - Kanadevia Corp.

Peers - HIZOF - Kanadevia Corp.

Peer Comparison

Compared with companies in Pollution & Treatment Controls listed on OTC.

Profile Summary - HIZOF - Kanadevia Corp.

About

Kanadevia Corp. is a pharmaceutical company specializing in the research, development, and commercialization of innovative healthcare solutions. The primary function of the company is to address unmet medical needs through its diverse range of products and therapies. With a focus on biotechnology, Kanadevia Corp. is…

SectorIndustrials
IndustryPollution & Treatment Controls
Employees12.14K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.